Zentek Company Description
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada.
The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.
The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021.
Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
Country | Canada |
Founded | 2008 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 24 |
CEO | Gregory Fenton |
Contact Details
Address: 24 Corporate Court Guelph, Ontario N1G 5G5 Canada | |
Phone | 844-730-9822 |
Website | zentek.com |
Stock Details
Ticker Symbol | ZEN |
Exchange | TSX Venture Exchange |
Fiscal Year | April - March |
Reporting Currency | CAD |
ISIN Number | CA98942X1024 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Gregory Fenton C.F.A. | Chief Executive Officer and Director |
Wendy Ford CA, CPA | Chief Financial Officer |
Dr. Colin van der Kuur B.Sc., DMIN | Chief Science Officer |
Ryan Shacklock | Senior Vice President of Strategy and Business Development |